JPS61500910A - 薬剤用制御放出性液状製剤 - Google Patents

薬剤用制御放出性液状製剤

Info

Publication number
JPS61500910A
JPS61500910A JP60500315A JP50031585A JPS61500910A JP S61500910 A JPS61500910 A JP S61500910A JP 60500315 A JP60500315 A JP 60500315A JP 50031585 A JP50031585 A JP 50031585A JP S61500910 A JPS61500910 A JP S61500910A
Authority
JP
Japan
Prior art keywords
coating
dosage form
liquid
coated
cellulose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP60500315A
Other languages
English (en)
Japanese (ja)
Inventor
ベントン，ベン・フランクリン
ガードナー，デビツド・リー
Original Assignee
バッテル・ディベロプメント・コ−ポレ−ション
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by バッテル・ディベロプメント・コ−ポレ−ション filed Critical バッテル・ディベロプメント・コ−ポレ−ション
Publication of JPS61500910A publication Critical patent/JPS61500910A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
JP60500315A 1984-01-13 1985-01-09 薬剤用制御放出性液状製剤 Pending JPS61500910A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US57046984A 1984-01-13 1984-01-13
US570469 1984-01-13
PCT/US1985/000042 WO1985003000A1 (en) 1984-01-13 1985-01-09 Controlled release liquid dosage formulations for pharmaceuticals

Publications (1)

Publication Number Publication Date
JPS61500910A true JPS61500910A (ja) 1986-05-08

Family

ID=24279767

Family Applications (1)

Application Number Title Priority Date Filing Date
JP60500315A Pending JPS61500910A (ja) 1984-01-13 1985-01-09 薬剤用制御放出性液状製剤

Country Status (11)

Country Link
EP (1) EP0169236A1 (US08177716-20120515-C00003.png)
JP (1) JPS61500910A (US08177716-20120515-C00003.png)
AU (1) AU3835885A (US08177716-20120515-C00003.png)
CA (1) CA1239347A (US08177716-20120515-C00003.png)
ES (1) ES8605975A1 (US08177716-20120515-C00003.png)
GR (1) GR850069B (US08177716-20120515-C00003.png)
IL (1) IL74049A0 (US08177716-20120515-C00003.png)
IT (1) IT1184309B (US08177716-20120515-C00003.png)
NZ (1) NZ210785A (US08177716-20120515-C00003.png)
WO (1) WO1985003000A1 (US08177716-20120515-C00003.png)
ZA (1) ZA85239B (US08177716-20120515-C00003.png)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004522797A (ja) * 2001-03-09 2004-07-29 エティファルム 味をマスキングした、顆粒及びコーティングされた顆粒剤

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE109659T1 (de) * 1986-03-21 1994-08-15 Eurasiam Lab Arzneimittelzusammensetzungen.
SE8605515D0 (sv) * 1986-12-22 1986-12-22 Astra Laekemedel Ab A liquid dosage form for oral administration of a pharmaceutically active substance
FI77573C (fi) * 1987-05-08 1989-04-10 Orion Yhtymae Oy Ny konsistens.
US5030454A (en) * 1987-10-26 1991-07-09 Alza Corporation Method for delivering drug in tiny pills in liquid carrier
US4853229A (en) * 1987-10-26 1989-08-01 Alza Corporation Method for adminstering tiny pills
IT1226940B (it) * 1988-09-16 1991-02-22 Recordati Chem Pharm Sistema terapeutico a rilascio controllato per formulazioni farmaceutiche liquide
US5296236A (en) * 1988-09-16 1994-03-22 Recordati S.A., Chemical And Pharmaceutical Company Controlled release therapeutic system for a liquid pharmaceutical formulations
US5202128A (en) * 1989-01-06 1993-04-13 F. H. Faulding & Co. Limited Sustained release pharmaceutical composition
EP0535937B2 (en) * 1991-10-01 2008-05-21 Takeda Chemical Industries, Ltd. Prolonged release microparticle preparation and production of the same
US5160742A (en) * 1991-12-31 1992-11-03 Abbott Laboratories System for delivering an active substance for sustained release
IL104093A (en) * 1991-12-31 1999-06-20 Abbott Lab Prolamine is expected to mask the taste of drugs given orally
AU4198793A (en) † 1992-07-24 1994-01-27 Takeda Chemical Industries Ltd. Microparticle preparation and production thereof
US5744164A (en) * 1994-12-16 1998-04-28 Nestec S.A. Sustained release microparticulate caffeine formulation
EP1165042B1 (fr) 1999-04-06 2005-02-02 Ethypharm Suspension pharmaceutique buvable d'ibuprofene
FR2791888B1 (fr) * 1999-04-06 2004-10-08 Ethypharm Lab Prod Ethiques Suspension pharmaceutique buvable
WO2004096175A2 (en) * 2003-04-30 2004-11-11 Ranbaxy Laboratories Limited Taste masked microcapsules and processes for their preparation
CA2959414C (en) 2014-09-05 2023-03-14 Symbiomix Therapeutics, Llc Secnidazole for use in the treatment of bacterial vaginosis

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2805977A (en) * 1955-01-04 1957-09-10 Smith Kline French Lab Sustained release pharmaceutical preparation
US3265629A (en) * 1958-12-22 1966-08-09 Ncr Co Coating by phase separation
US3432593A (en) * 1963-09-18 1969-03-11 Key Pharm Inc Delayed and sustained release type pharmaceutical preparation

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004522797A (ja) * 2001-03-09 2004-07-29 エティファルム 味をマスキングした、顆粒及びコーティングされた顆粒剤

Also Published As

Publication number Publication date
CA1239347A (en) 1988-07-19
GR850069B (US08177716-20120515-C00003.png) 1985-05-03
ES8605975A1 (es) 1986-04-01
IT1184309B (it) 1987-10-28
WO1985003000A1 (en) 1985-07-18
EP0169236A1 (en) 1986-01-29
ZA85239B (en) 1985-08-28
NZ210785A (en) 1987-11-27
IT8519086A0 (it) 1985-01-11
IL74049A0 (en) 1985-04-30
AU3835885A (en) 1985-07-30
ES539500A0 (es) 1986-04-01

Similar Documents

Publication Publication Date Title
JPS61500910A (ja) 薬剤用制御放出性液状製剤
US4876094A (en) Controlled release liquid dosage formulation
EP0235718B1 (en) Granule remaining in stomach
EP0619733B1 (en) System for delivering an active substance for sustained release
EP0277127B1 (en) New drug preparation with controlled release of the active compound, and a method for the manufacture thereof
US4574080A (en) Combination formulation
US3109775A (en) Theophylline-noscapine sustained release composition for treatment of asthma
US20050181047A1 (en) Compositions and methods for timed release of water-soluble nutritional supplements
FI96095C (fi) Menetelmä jatkuvavapautteisen lääkevalmisteen valmistamiseksi
AU2018100110A4 (en) Ubiquinone And Ubiquinol Compositions, And Methods Relating Thereto
IL21981A (en) Delayed action medicinal preparation
JPH06199683A (ja) シクロスポリン含有医薬組成物
JPH11509523A (ja) オメガ−３ポリ不飽和酸の経口投与剤を用いた炎症性腸疾患の治療方法
IE48891B1 (en) A pharmaceutical preparation comprising a cardiac glycoside with a polymer coating,and a process for preparation thereof
DK151608B (da) Fremgangsmaade til fremstilling af et farmaceutisk peroralt polydepotpraeparat med kontrolleret afgivelse
SE426548B (sv) Fast farmaceutisk beredning innehallande en terapeutiskt effektiv hjertglykosid och en polymer
JP2008536879A (ja) 薬物又は栄養物の組合物調剤及び調合剤、その内服による吸収を改善する方法、及びその応用方法
US20050181044A1 (en) Compositions and methods for timed release of water-soluble nutritional supplements, green coffee extract
JPS5988420A (ja) シ−ムレスカプセル化ニフエジピン製剤
JPH06219942A (ja) トラネキサム酸配合ゼラチンカプセル製剤
GB2300807A (en) Oral dosage forms of omega-3 polyunsaturated acids for the treatment of inflammatory bowel disease
CN101002736A (zh) 雷公藤多苷的缓释制剂
WO2001028516A2 (en) Sustained-release formulations for treating cns-mediated disorders
US11833182B2 (en) Sleep product
JPS6322014A (ja) 胃内浮遊性持続型カプセル剤